Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Mordenti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|June 2, 2007
In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatographyTong Lin, Kristine Pan, Joyce Mordenti, et al.
American Journal of Therapeutics|March 1, 1995
Bioequivalence of Two Recombinant Human Growth Hormones in Healthy Male Volunteers after Subcutaneous AdministrationSharon A. Chen, Allen E. Izu, Joyce Mordenti, et al.
Pharmaceutical Research|April 14, 2016
Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine ExampleMarci L Chew, Joyce Mordenti, Thean Yeoh, et al.
Clinical Pharmacokinetics|April 29, 2015
Clinical Pharmacokinetic Studies of EnzalutamideJacqueline A Gibbons, Taoufik Ouatas, Walter Krauwinkel, et al.
Clinical Pharmacokinetics|May 2, 2015
Pharmacokinetic Drug Interaction Studies with EnzalutamideJacqueline A Gibbons, Michiel de Vries, Walter Krauwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Small molecule inhibitors of plasma kallikreinWendy B Young, Roopa Rai, William D Shrader, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailabilityJennifer R Riggs, Aleksandr Kolesnikov, John Hendrix, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Factor VIIa inhibitors: improved pharmacokinetic parametersAleksandr Kolesnikov, Roopa Rai, Wendy B Young, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis modelWendy B Young, Joyce Mordenti, Steven Torkelson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|June 2, 2007
In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatographyTong Lin, Kristine Pan, Joyce Mordenti, et al.
American Journal of Therapeutics|March 1, 1995
Bioequivalence of Two Recombinant Human Growth Hormones in Healthy Male Volunteers after Subcutaneous AdministrationSharon A. Chen, Allen E. Izu, Joyce Mordenti, et al.
Pharmaceutical Research|April 14, 2016
Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine ExampleMarci L Chew, Joyce Mordenti, Thean Yeoh, et al.
Clinical Pharmacokinetics|April 29, 2015
Clinical Pharmacokinetic Studies of EnzalutamideJacqueline A Gibbons, Taoufik Ouatas, Walter Krauwinkel, et al.
Clinical Pharmacokinetics|May 2, 2015
Pharmacokinetic Drug Interaction Studies with EnzalutamideJacqueline A Gibbons, Michiel de Vries, Walter Krauwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Small molecule inhibitors of plasma kallikreinWendy B Young, Roopa Rai, William D Shrader, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailabilityJennifer R Riggs, Aleksandr Kolesnikov, John Hendrix, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Factor VIIa inhibitors: improved pharmacokinetic parametersAleksandr Kolesnikov, Roopa Rai, Wendy B Young, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis modelWendy B Young, Joyce Mordenti, Steven Torkelson, et al.
Pageof 1